1.Sales and profit
See section β- Exicure, Inc. had $0.0M of revenue in fiscal 2025, down 100.0% on the year before.
- Exicure, Inc. lost $4.9M in fiscal 2025.
Exicure, Inc.
XCUR Nasdaq Pharmaceutical Preparations Financials FY2016βFY2025
Exicure, Inc. had $0.0M of revenue in fiscal 2025, down 100.0% on the year before.
Last close Β· Oct 23, 2026
$1.05
7.1%KIRAβs summary AI analyst
Hi! I read Exicure, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
4 to watch
2.Cash and shareholders
See section β- Free cash flow was β$8.6M in fiscal 2025, β of revenue.
- In the last 12 months, insiders sold $11.6M of shares on the open market and bought none.
3.Financial health
See section β- Exicure, Inc. passes 1 of 7 financial health tests (Piotroski F-score).
Exicure, Inc. in 30 seconds
Good So-so Weak
Weak
Are sales growing?
β100.0%
No. Sales fell 100.0% last year.
Weak
Does it make a profit?
β$4.9M
No. It lost money last year.
Weak
How healthy are the accounts?
1 / 7
Weak. It passes 1 of 7 health tests.
For information
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Key numbers, fiscal 2025
Market cap
Last close times the latest diluted share count, so it is approximate.
$6.7M
Oct 23 close
P/E
Last close divided by diluted earnings per share over the last four quarters.
β
On β$1.34 EPS (TTM)
Charts by
Sales and profit
Is it selling more, and how much does it keep?
Revenue and margins
KIRA Β· Exicure, Inc. had $0.0M of revenue in fiscal 2025, down 100.0% on the year before.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
FY16
Revenue $1.0M
FY17
Revenue $9.7M
FY18
Revenue $0.1M
FY19
Revenue $1.3M
FY20
Revenue $16.6M
FY21
Revenue β$0.5M
FY22
Revenue $28.8M
FY23
Revenue $0.0M
FY24
Revenue $0.5M
FY25
Revenue $0.0M
Revenue
Q3 '23
Revenue $0.0M
Q4 '23
Revenue $0.0M
Q1 '24
Revenue $0.5M
Q2 '24
Revenue $0.0M
Q3 '24
Revenue $0.0M
Q4 '24
Revenue $0.0M
Q1 '25
Revenue $0.0M
Q2 '25
Revenue $0.0M
Q3 '25
Revenue $0.0M
Q4 '25
Revenue $0.0M
Q1 '26
Revenue $0.0M
Q2 '26
Revenue $0.0M
Margins, % of revenue
FY16
Gross β
Operating β1,560.0%
Net β1,635.2%
FCF β525.5%
FY17
Gross β
Operating β107.1%
Net β113.3%
FCF β213.1%
FY18
Gross β
Operating β18,490.7%
Net β18,994.1%
FCF β16,594.1%
FY19
Gross β
Operating β2,053.8%
Net β2,029.6%
FCF 18.1%
FY20
Gross β
Operating β153.1%
Net β148.5%
FCF β255.5%
FY21
Gross β
Operating 12,950.1%
Net 13,271.6%
FCF 7,409.3%
FY22
Gross β
Operating β6.4%
Net β9.0%
FCF β123.7%
FY23
Gross β
Operating β
Net β
FCF β
FY24
Gross β
Operating β2,446.4%
Net β1,940.2%
FCF β582.0%
FY25
Gross β
Operating β
Net β
FCF β
Gross
Operating
Net
FCF
Margins, % of revenue
Q3 '23
Gross β
Operating β
Net β
FCF β
Q4 '23
Gross β
Operating β
Net β
FCF β
Q1 '24
Gross β
Operating β167.2%
Net β165.8%
FCF β
Q2 '24
Gross β
Operating β
Net β
FCF β
Q3 '24
Gross β
Operating β
Net β
FCF β
Q4 '24
Gross β
Operating β
Net β
FCF β
Q1 '25
Gross β
Operating β
Net β
FCF β
Q2 '25
Gross β
Operating β
Net β
FCF β
Q3 '25
Gross β
Operating β
Net β
FCF β
Q4 '25
Gross β
Operating β
Net β
FCF β
Q1 '26
Gross β
Operating β
Net β
FCF β
Q2 '26
Gross β
Operating β
Net β
FCF β
Gross
Operating
Net
FCF
Net income and earnings per share
KIRA Β· Exicure, Inc. lost $4.9M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
FY16
Net income β$16.9M
FY17
Net income β$11.0M
FY18
Net income β$22.4M
FY19
Net income β$26.3M
FY20
Net income β$24.7M
FY21
Net income β$64.1M
FY22
Net income β$2.6M
FY23
Net income β$16.9M
FY24
Net income β$9.7M
FY25
Net income β$4.9M
Net income
Q3 '23
Net income β$5.3M
Q4 '23
Net income β$1.5M
Q1 '24
Net income β$0.8M
Q2 '24
Net income β$0.6M
Q3 '24
Net income β$1.1M
Q4 '24
Net income β$7.2M
Q1 '25
Net income $3.0M
Q2 '25
Net income β$2.6M
Q3 '25
Net income β$2.4M
Q4 '25
Net income β$2.9M
Q1 '26
Net income β$1.8M
Q2 '26
Net income β$1.1M
Diluted EPS
FY16
Diluted EPS β$149.37
FY17
Diluted EPS β$1.09
FY18
Diluted EPS β$0.54
FY19
Diluted EPS β$0.46
FY20
Diluted EPS β$0.28
FY21
Diluted EPS β$21.70
FY22
Diluted EPS β$0.56
FY23
Diluted EPS β$10.55
FY24
Diluted EPS β$4.75
FY25
Diluted EPS β$0.79
Diluted EPS
Q3 '23
Diluted EPS β$3.04
Q4 '23
Diluted EPS β$6.13
Q1 '24
Diluted EPS β$0.48
Q2 '24
Diluted EPS β$0.35
Q3 '24
Diluted EPS β$0.57
Q4 '24
Diluted EPS β$3.35
Q1 '25
Diluted EPS $0.49
Q2 '25
Diluted EPS β$0.41
Q3 '25
Diluted EPS β$0.39
Q4 '25
Diluted EPS β$0.48
Q1 '26
Diluted EPS β$0.29
Q2 '26
Diluted EPS β$0.18
Cash and shareholders
How much cash comes in, and where does it go?
Cash flow
KIRA Β· Free cash flow was β$8.6M in fiscal 2025, β of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
FY16
Free cash flow β$5.4M
FY17
Free cash flow β$20.7M
FY18
Free cash flow β$19.6M
FY19
Free cash flow $0.2M
FY20
Free cash flow β$42.4M
FY21
Free cash flow β$35.8M
FY22
Free cash flow β$35.7M
FY23
Free cash flow β$10.4M
FY24
Free cash flow β$2.9M
FY25
Free cash flow β$8.6M
Free cash flow
Q3 '23
Free cash flow β$1.4M
Q4 '23
Free cash flow β$0.8M
Q1 '24
Free cash flow β
Q2 '24
Free cash flow β
Q3 '24
Free cash flow β$0.4M
Q4 '24
Free cash flow β$0.8M
Q1 '25
Free cash flow β
Q2 '25
Free cash flow β
Q3 '25
Free cash flow β$3.4M
Q4 '25
Free cash flow β$0.9M
Q1 '26
Free cash flow β
Q2 '26
Free cash flow β
Cash from operations vs capital spending
FY16
Cash from operations β$5.1M
Capital spending $0.4M
FY17
Cash from operations β$19.8M
Capital spending $0.9M
FY18
Cash from operations β$19.5M
Capital spending $0.1M
FY19
Cash from operations $1.3M
Capital spending $1.1M
FY20
Cash from operations β$39.3M
Capital spending $3.2M
FY21
Cash from operations β$34.8M
Capital spending $1.0M
FY22
Cash from operations β$35.7M
Capital spending $0.0M
FY23
Cash from operations β$10.4M
Capital spending $0.0M
FY24
Cash from operations β$2.9M
Capital spending $0.0M
FY25
Cash from operations β$8.6M
Capital spending $0.0M
Cash from operations
Capital spending
Cash from operations vs capital spending
Q3 '23
Cash from operations β$1.4M
Capital spending $0.0M
Q4 '23
Cash from operations β$0.8M
Capital spending $0.0M
Q1 '24
Cash from operations β$0.5M
Capital spending β
Q2 '24
Cash from operations β$1.2M
Capital spending β
Q3 '24
Cash from operations β$0.4M
Capital spending $0.0M
Q4 '24
Cash from operations β$0.8M
Capital spending $0.0M
Q1 '25
Cash from operations β$1.6M
Capital spending β
Q2 '25
Cash from operations β$2.3M
Capital spending β
Q3 '25
Cash from operations β$3.5M
Capital spending β$0.1M
Q4 '25
Cash from operations β$1.1M
Capital spending β$0.2M
Q1 '26
Cash from operations β$1.1M
Capital spending β
Q2 '26
Cash from operations β$0.9M
Capital spending β
Cash from operations
Capital spending
Dividends, buybacks and share count
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
FY16
Dividends β
Buybacks β
FY17
Dividends β
Buybacks β
FY18
Dividends β
Buybacks β
FY19
Dividends β
Buybacks β
FY20
Dividends β
Buybacks β
FY21
Dividends β
Buybacks β
FY22
Dividends β
Buybacks β
FY23
Dividends β
Buybacks β
FY24
Dividends β
Buybacks β
FY25
Dividends β
Buybacks β
Dividends
Buybacks
Diluted shares outstanding (annual)
FY16
Diluted shares 0.00B
FY17
Diluted shares 0.01B
FY18
Diluted shares 0.04B
FY19
Diluted shares 0.06B
FY20
Diluted shares 0.09B
FY21
Diluted shares 0.00B
FY22
Diluted shares 0.00B
FY23
Diluted shares 0.00B
FY24
Diluted shares 0.00B
FY25
Diluted shares 0.01B
Insider trades
KIRA Β· In the last 12 months, insiders sold $11.6M of shares on the open market and bought none.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$11.6M
2 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jan 21, 2026 | Exicure HiTron Inc.10% owner | Sold | 258,367 | $4.50 | $1.2M | Form 4 |
| Jan 16, 2026 | Exicure HiTron Inc.10% owner | Sold | 734,747 | $4.50 | $3.3M | Form 4 |
| Jan 7, 2026 | Exicure HiTron Inc.10% owner | Sold | 741,272 | $4.50 | $3.3M | Form 4 |
| Dec 8, 2025 | Sangsangin Investment & Securities Co., LTD.10% owner | Sold | 433,332 | $8.71 | $3.8M | Form 4 |
Financial health
Can it carry its debts, and how well does it use its money?
Balance sheet
Cash, debt and the ratios that show how comfortably Exicure, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
FY16
Cash $19.6M
Debt $5.7M
FY17
Cash $25.8M
Debt $4.9M
FY18
Cash $26.3M
Debt $4.9M
FY19
Cash $111M
Debt $5.0M
FY20
Cash $82.1M
Debt $16.6M
FY21
Cash $39.1M
Debt $6.9M
FY22
Cash $8.6M
Debt $0.0M
FY23
Cash $0.8M
Debt $0.0M
FY24
Cash $12.5M
Debt β
FY25
Cash $3.7M
Debt β
Cash
Debt
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $39.1M | $8.6M | $0.8M | $12.5M | $3.7M |
| Debt incl. finance leases | $6.9M | $0.0M | $0.0M | β | β |
| Debt / equity | 0.6x | 0.0x | 0.0x | β | β |
| Interest coverage | β37.0x | β3.1x | β | β679.6x | β4,233.0x |
| Current ratio | 1.3x | 6.1x | 0.8x | 4.5x | 1.2x |
| Quick ratio | 1.3x | 6.1x | 0.8x | 4.5x | 1.2x |
| Total assets | $64.9M | $23.3M | $11.6M | $15.1M | $14.0M |
| Total liabilities | $53.6M | $8.4M | $8.5M | $8.3M | $10.1M |
| Shareholders' equity | $11.2M | $14.9M | $3.0M | $6.8M | $3.9M |
| Net debt (β = net cash) | β$32.3M | β$8.6M | β$0.8M | β | β |
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
FY16
Return on capital β
Return on equity β692.0%
Return on assets β82.3%
FY17
Return on capital β
Return on equity β98.2%
Return on assets β44.4%
FY18
Return on capital β
Return on equity β109.5%
Return on assets β77.6%
FY19
Return on capital β
Return on equity β51.7%
Return on assets β36.5%
FY20
Return on capital β
Return on equity β34.7%
Return on assets β22.9%
FY21
Return on capital β
Return on equity β176.3%
Return on assets β77.6%
FY22
Return on capital β22.8%
Return on equity β19.7%
Return on assets β5.9%
FY23
Return on capital β534.8%
Return on equity β188.4%
Return on assets β96.9%
FY24
Return on capital β
Return on equity β197.9%
Return on assets β72.8%
FY25
Return on capital β
Return on equity β92.5%
Return on assets β34.0%
Return on capital
Return on equity
Return on assets
Piotroski F-score
KIRA Β· Exicure, Inc. passes 1 of 7 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 2 / 8 | 5 / 8 | 2 / 8 | 3 / 8 | 4 / 8 | 2 / 8 | 4 / 7 | 1 / 7 |
| Accruals ratio | β57.8% | 35.4% | β10.1% | β38.4% | 13.5% | β35.4% | 75.0% | β37.6% | β51.0% | 24.8% |
| Altman Z'' | β6.20 | 1.63 | β2.67 | 3.25 | 1.26 | β13.84 | β20.43 | β61.97 | β43.13 | β48.69 |
All figures
Every number, year by year.
10 years of figures
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.0M | $9.7M | $0.1M | $1.3M | $16.6M | β$0.5M | $28.8M | $0.0M | $0.5M | $0.0M |
| Research and development | $13.7M | $13.1M | $14.1M | $19.3M | $32.1M | $49.0M | $19.8M | $1.4M | $0.0M | $3.3M |
| Operating income | β$16.2M | β$10.4M | β$21.8M | β$26.6M | β$25.4M | β$62.5M | β$1.8M | β$15.0M | β$12.2M | β$4.2M |
| Interest expense | $0.7M | $0.8M | $0.7M | $0.8M | $0.6M | $1.7M | $0.6M | $0.0M | $0.0M | $0.0M |
| Pretax income | β$16.9M | β$12.0M | β | β$26.3M | β$24.7M | β$64.1M | β$2.4M | β$16.9M | β$9.7M | β$5.6M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.2M | $0.0M | $0.0M | β$0.6M |
| Net income | β$16.9M | β$11.0M | β$22.4M | β$26.3M | β$24.7M | β$64.1M | β$2.6M | β$16.9M | β$9.7M | β$4.9M |
| Net income to common | β | β | β | β | β$24.7M | β$64.1M | β$2.6M | β$16.9M | β$9.7M | β$4.9M |
| Diluted EPS | β$149.37 | β$1.09 | β$0.54 | β$0.46 | β$0.28 | β$21.70 | β$0.56 | β$10.55 | β$4.75 | β$0.79 |
| Diluted shares | 0.00B | 0.01B | 0.04B | 0.06B | 0.09B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | β$5.1M | β$19.8M | β$19.5M | $1.3M | β$39.3M | β$34.8M | β$35.7M | β$10.4M | β$2.9M | β$8.6M |
| Capital expenditure | $0.4M | $0.9M | $0.1M | $1.1M | $3.2M | $1.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Free cash flow | β$5.4M | β$20.7M | β$19.6M | $0.2M | β$42.4M | β$35.8M | β$35.7M | β$10.4M | β$2.9M | β$8.6M |
| Depreciation and amortization | $0.2M | $0.2M | $0.4M | $0.4M | $0.8M | $1.1M | $1.2M | $0.6M | $0.0M | $0.2M |
| Stock-based compensation | $0.7M | $1.5M | $1.8M | $1.8M | $2.2M | $2.9M | $1.4M | $1.3M | $0.0M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $19.6M | $25.8M | $26.3M | $111M | $82.1M | $39.1M | $8.6M | $0.8M | $12.5M | $3.7M |
| Total debt | $5.7M | $4.9M | $4.9M | $5.0M | $16.6M | $6.9M | $0.0M | $0.0M | β | β |
| Current assets | $20.0M | $27.6M | $27.7M | $113M | $86.3M | $43.7M | $10.1M | $2.0M | $13.7M | $4.6M |
| Current liabilities | $12.2M | $3.4M | $2.0M | $31.1M | $13.7M | $34.1M | $1.6M | $2.5M | $3.1M | $3.9M |
| Property and equipment, net | $0.5M | $1.3M | $1.1M | $2.1M | $4.1M | $3.9M | $2.5M | $0.1M | $0.0M | $0.3M |
| Goodwill | β | β | β | β | β | β | β | β | $0.0M | $4.4M |
| Intangible assets | β | β | β | β | β | β | β | β | $0.0M | $3.8M |
| Total assets | $20.6M | $29.0M | $28.8M | $115M | $100M | $64.9M | $23.3M | $11.6M | $15.1M | $14.0M |
| Total liabilities | $18.1M | $9.0M | $7.8M | $34.5M | $38.9M | $53.6M | $8.4M | $8.5M | $8.3M | $10.1M |
| Preferred stock | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $2.4M | $20.0M | $21.0M | $80.7M | $61.5M | $11.2M | $14.9M | $3.0M | $6.8M | $3.9M |
| Margins | ||||||||||
| Operating margin | β1,560.0% | β107.1% | β18,490.7% | β2,053.8% | β153.1% | 12,950.1% | β6.4% | β | β2,446.4% | β |
| EBITDA margin | β1,542.7% | β104.7% | β18,187.3% | β2,023.5% | β148.5% | 12,717.6% | β2.3% | β | β2,440.8% | β |
| Net margin | β1,635.2% | β113.3% | β18,994.1% | β2,029.6% | β148.5% | 13,271.6% | β9.0% | β | β1,940.2% | β |
| FCF margin | β525.5% | β213.1% | β16,594.1% | 18.1% | β255.5% | 7,409.3% | β123.7% | β | β582.0% | β |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | β | β22.8% | β534.8% | β | β |
| Return on capital employed | β192.0% | β40.6% | β81.7% | β31.6% | β29.3% | β203.1% | β8.4% | β165.3% | β102.1% | β41.7% |
| Return on equity | β692.0% | β98.2% | β109.5% | β51.7% | β34.7% | β176.3% | β19.7% | β188.4% | β197.9% | β92.5% |
| Return on assets | β82.3% | β44.4% | β77.6% | β36.5% | β22.9% | β77.6% | β5.9% | β96.9% | β72.8% | β34.0% |
| Return on tangible equity | β692.0% | β55.1% | β107.0% | β32.6% | β40.1% | β570.7% | β17.3% | β558.0% | β143.3% | β |
| Growth | ||||||||||
| Revenue growth | β | 838.1% | β98.8% | 998.3% | 1,181.9% | β102.9% | β | β100.0% | β | β100.0% |
| FCF growth | β | β | β | β | β18,160.0% | β | β | β | β | β |
| Share count change | β | 8,823.8% | 307.0% | 40.0% | 51.2% | β96.6% | 56.4% | β65.3% | 27.5% | 208.2% |
| Financial health | ||||||||||
| Debt / equity | 2.3x | 0.2x | 0.2x | 0.1x | 0.3x | 0.6x | 0.0x | 0.0x | β | β |
| Interest coverage | β22.3x | β13.1x | β32.5x | β33.9x | β44.4x | β37.0x | β3.1x | β | β679.6x | β4,233.0x |
| Current ratio | 1.6x | 8.2x | 13.5x | 3.6x | 6.3x | 1.3x | 6.1x | 0.8x | 4.5x | 1.2x |
| Quick ratio | 1.6x | 8.2x | 13.5x | 3.6x | 6.3x | 1.3x | 6.1x | 0.8x | 4.5x | 1.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 38.0% | 9.5% | 79.7% | 83.5% | 19.1% | β200.4% | 0.0% | β | 0.0% | β |
| Stock comp / revenue | 65.8% | 15.0% | 1,533.1% | 142.0% | 13.1% | β608.5% | 4.7% | β | 4.4% | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 2.0 | 5.0 | 2.0 | 3.0 | 4.0 | 2.0 | 4.0 | 1.0 |
| Altman Z'' | β6.2 | 1.6 | β2.7 | 3.3 | 1.3 | β13.8 | β20.4 | β62.0 | β43.1 | β48.7 |
| Accruals ratio | β57.8% | 35.4% | β10.1% | β38.4% | 13.5% | β35.4% | 75.0% | β37.6% | β51.0% | 24.8% |
Source: SEC EDGAR XBRL filings (CIK 0001698530). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.